<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Guideline</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Guideline.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/study-types/guideline.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Streptococcus suis meningitis complicated with communicating hydrocephalus: complete clinical and radiological resolution with non-neurosurgical management—A case report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</guid>
    <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
    <description>The case suggests that contrast-enhanced MRI for accurate hydrocephalus subtyping and rapid pathogen identification via metagenomic sequencing may inform decisions about non-neurosurgical management in selected S. suis meningitis cases with communicating hydrocephalus.</description>
    <category>Streptococcus suis</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Hemoadsorption Therapy for Expanded Dengue Syndrome Patients : A Case Series Study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Expanded dengue syndrome represents a rare but severe manifestation of dengue infection with multi-organ involvement and high fatality risk. The case series suggests hemoadsorption may offer a treatment option when standard intensive care fails, though the evidence base is limited to three cases.</description>
    <category>Dengue</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Management of neonates born to mothers with reactive serologic tests for syphilis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review is framed around the U.S. resurgence of maternal and congenital syphilis, noting associated neonatal morbidity and mortality and calling for more practical, safe management approaches.</description>
    <category>Syphilis</category>
    <category>Congenital syphilis</category>
    <category>Syphilis in pregnancy</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>The Application and Impact of Digital Patient Decision Aids in COPD : A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</guid>
    <pubDate>Sun, 16 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review frames digital patient decision aids as a possible support for shared decision-making in COPD, with outcome evidence centered on decision quality and user experience measures.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Maternal HIV viral load threshold for guiding extended infant prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies - an expert meeting report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</guid>
    <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
    <description>By establishing uniform evaluation criteria and mapping financial requirements, the report aims to accelerate the deployment of accessible testing instruments that align with regional elimination timelines.</description>
    <category>Chagas disease</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The article provides an evidence-based framework for selecting antiviral treatments for adults with mild to moderate COVID-19. The supplied abstract does not report population-level outcomes or surveillance findings.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106635-94449766/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106635-94449766/</guid>
    <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
    <description>These observations underscore evolving transmission patterns and atypical disease manifestations that may necessitate adjustments to routine immunization schedules and travel-related health advisories.</description>
    <category>COVID-19</category>
    <category>Meningococcal disease</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Travel medicine</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7435a1-0033bc2a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7435a1-0033bc2a/</guid>
    <pubDate>Thu, 18 Sep 2025 00:00:00 GMT</pubDate>
    <description>With approximately 39,000 new HIV diagnoses annually in the United States and suboptimal adherence to existing oral and injectable PrEP regimens, a strongly recommended 6-month injectable option may improve adherence and strengthen HIV prevention efforts.</description>
    <category>AIDS</category>
    <category>HIV infection</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Estimating the risk and spatial spread of measles in populations with high MMR uptake: Using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004466-7da89bf9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004466-7da89bf9/</guid>
    <pubDate>Tue, 08 Oct 2024 00:00:00 GMT</pubDate>
    <description>Clustering of unvaccinated children across primary and connected secondary schools can sustain sizable measles outbreaks even where national coverage exceeds 95%, suggesting that school-network structure is relevant for outbreak preparedness and response.</description>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Using the WHO-INTEGRATE framework to develop a COVID-19 guideline for schools, Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-291550-07993e23/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-291550-07993e23/</guid>
    <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
    <description>The guideline addressed a critical gap in reliable, globally applicable recommendations for safe and continuous school operations during the COVID-19 pandemic. The WHO-INTEGRATE framework supported transparent, structured decision-making with a whole-of-society perspective on measures to reduce SARS-CoV-2 transmission in schools.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Health policy</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</guid>
    <pubDate>Thu, 12 Sep 2024 00:00:00 GMT</pubDate>
    <description>The guideline addresses a health disparity by offering AI/AN communities an additional vaccine option that maintains early protection against invasive Hib disease while simplifying infant immunization schedules through a combination vaccine. It may improve vaccine uptake and coverage in a high-risk population.</description>
    <category>Haemophilus influenzae</category>
    <category>Influenza</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Clinical and epidemiological features of imported loiasis in Beijing: a report from patients returned from Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09620-6-973b17d2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09620-6-973b17d2/</guid>
    <pubDate>Sat, 20 Jul 2024 00:00:00 GMT</pubDate>
    <description>The report provides context for recognizing and evaluating imported loiasis in a non-endemic setting, particularly among people returning from prolonged stays in endemic African regions. It may support clinical and laboratory awareness, but the supplied evidence does not establish population-level frequency or broader public health impact.</description>
    <category>Filariasis</category>
    <category>Travel medicine</category>
    <category>Treatment</category>
    <category>Genomic epidemiology</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004325-c81d8d57/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004325-c81d8d57/</guid>
    <pubDate>Fri, 12 Jan 2024 00:00:00 GMT</pubDate>
    <description>The forecasted rise in comorbidity and multimorbidity among people aging with HIV has implications for clinical workforce preparedness, subspecialty care linkages, and resource allocation. Clinicians will need to remain current on evolving comorbidity-specific guidelines, and policymakers must support extended clinical capacity to meet complex healthcare needs.</description>
    <category>AIDS</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Digital measurement of SARS-CoV-2 transmission risk from 7 million contacts</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-023-06952-2-cf33638e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-023-06952-2-cf33638e/</guid>
    <pubDate>Wed, 20 Dec 2023 00:00:00 GMT</pubDate>
    <description>The findings challenge the widely used 2-meter, 15-minute guideline for contact tracing and demonstrate that privacy-preserving digital contact-tracing data can rapidly inform public health measures during emerging pathogen outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciad385-5d2f27f7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciad385-5d2f27f7/</guid>
    <pubDate>Fri, 23 Jun 2023 00:00:00 GMT</pubDate>
    <description>The findings demonstrate partial but incomplete guideline adoption, suggesting opportunities to improve standardization of care and reduce unnecessary diagnostic testing in pediatric pneumonia management.</description>
    <category>COVID-19</category>
    <category>Health policy</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Update of drug-resistant tuberculosis treatment guidelines: A turning point</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-03-013-84db036f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-03-013-84db036f/</guid>
    <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
    <description>The updated guidelines establish a shorter, all-oral, and more patient-centered approach to MDR/RR-TB management, potentially improving treatment acceptability and equity.</description>
    <category>Tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Review of 2022 WHO guidelines on the control and elimination of schistosomiasis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-22-00221-3-4054579e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-22-00221-3-4054579e/</guid>
    <pubDate>Tue, 01 Nov 2022 00:00:00 GMT</pubDate>
    <description>The review is relevant to policy and program implementation because it describes guidance intended to improve control and support elimination efforts. It also frames the implications of expanded treatment coverage for public health practice.</description>
    <category>Schistosomiasis</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Essential Emergency and Critical Care: a consensus among global clinical experts</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2021-006585-4f7d843a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2021-006585-4f7d843a/</guid>
    <pubDate>Tue, 21 Sep 2021 00:00:00 GMT</pubDate>
    <description>Critical illness causes millions of preventable deaths annually, and many basic life-saving interventions are overlooked in health systems. The authors suggest that implementing EECC could serve as a policy strategy to reduce preventable mortality worldwide.</description>
    <category>COVID-19</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30847-1-a19bd53e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30847-1-a19bd53e/</guid>
    <pubDate>Tue, 01 Jun 2021 00:00:00 GMT</pubDate>
    <description>The article provides a framework for more consistent case characterization and treatment decisions for COVID-19-associated pulmonary aspergillosis, including consideration of azole resistance. The supplied evidence does not quantify disease burden, treatment effects, or mortality.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Health policy</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Fluorescence polarization assay improves the rapid detection of human brucellosis in China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-021-00834-3-d6cc6424/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-021-00834-3-d6cc6424/</guid>
    <pubDate>Wed, 31 Mar 2021 00:00:00 GMT</pubDate>
    <description>Accurate rapid detection facilitates better management and control strategies for this zoonotic condition. The results indicate potential for integrating this technology into regional diagnostic workflows.</description>
    <category>Brucellosis</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab048-0564f4df/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab048-0564f4df/</guid>
    <pubDate>Fri, 22 Jan 2021 00:00:00 GMT</pubDate>
    <description>Universal access to accurate SARS-CoV-2 nucleic acid testing is described as critical for patient care, hospital infection prevention, and the public health response to the pandemic.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0008659-b164e23b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0008659-b164e23b/</guid>
    <pubDate>Mon, 28 Sep 2020 00:00:00 GMT</pubDate>
    <description>The findings are relevant to hospital treatment policy and guideline maintenance for melioidosis in tropical settings.</description>
    <category>Melioidosis</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciz1186-dccdce91/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciz1186-dccdce91/</guid>
    <pubDate>Fri, 13 Dec 2019 00:00:00 GMT</pubDate>
    <description>Rising antibiotic resistance poses particular concern in low- and middle-income countries with higher perinatal HIV exposure rates and wider cotrimoxazole prophylaxis use. Findings may inform revisions to current infant prophylaxis guidelines.</description>
    <category>AIDS</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-3826-5-6e1ce371/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-3826-5-6e1ce371/</guid>
    <pubDate>Fri, 15 Mar 2019 00:00:00 GMT</pubDate>
    <description>The high prevalence of advanced HIV disease at ART initiation and numerous missed opportunities for prevention and early diagnosis suggest substantial gaps in implementing WHO guidelines, indicating potential for preventable HIV-associated morbidity and mortality in Senegal.</description>
    <category>AIDS</category>
    <category>Tuberculosis</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6722a5-93f3336a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6722a5-93f3336a/</guid>
    <pubDate>Fri, 08 Jun 2018 00:00:00 GMT</pubDate>
    <description>The document establishes updated parameters for national influenza prevention strategies and guides healthcare providers on current vaccine selection criteria.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2017-06-023-93ef9dd1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2017-06-023-93ef9dd1/</guid>
    <pubDate>Fri, 01 Dec 2017 00:00:00 GMT</pubDate>
    <description>The recommendations address prevention and management of HBV reactivation, which is associated with high morbidity and mortality in haematologic patients, and provide vaccination guidance applicable across this immunocompromised population.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2016-03-010-1a5ea5d1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2016-03-010-1a5ea5d1/</guid>
    <pubDate>Mon, 01 Aug 2016 00:00:00 GMT</pubDate>
    <description>The update was intended to improve consistency in CDI diagnosis for surveillance purposes across Europe. The abstract does not provide evidence that the recommendations changed public health outcomes.</description>
    <category>Gastroenteritis</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciw360-97a26986/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciw360-97a26986/</guid>
    <pubDate>Wed, 27 Jul 2016 00:00:00 GMT</pubDate>
    <description>The guideline emphasizes that residence in and recent travel to endemic areas are critical for accurate recognition of infected patients, and addresses preemptive management after unintentional laboratory exposure.</description>
    <category>Coccidioidomycosis</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu617-bb6322ca/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu617-bb6322ca/</guid>
    <pubDate>Wed, 17 Sep 2014 00:00:00 GMT</pubDate>
    <description>The guideline addresses a clinically relevant intersection of HIV and chronic kidney disease and frames clinical decision-making for affected patients.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Eliminating mother-to-child HIV transmission in South Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-12-106807-e1a8b381/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-12-106807-e1a8b381/</guid>
    <pubDate>Mon, 19 Nov 2012 00:00:00 GMT</pubDate>
    <description>Demonstrates how coordinated policy adoption and infrastructure expansion can improve preventive care delivery and lower disease burden in high-prevalence regions.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</guid>
    <pubDate>Thu, 31 May 2012 00:00:00 GMT</pubDate>
    <description>The findings provide comparative information about European vaccination strategies, suggesting that understanding diverse approaches may help countries adapt their programmes. High compliance has been achieved in many European programmes using only recommendations rather than mandates.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Poliomyelitis</category>
    <category>Hepatitis B</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1086-522765-0aa2f451/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1086-522765-0aa2f451/</guid>
    <pubDate>Thu, 15 Nov 2007 00:00:00 GMT</pubDate>
    <description>Standardized clinical practice guidelines support consistent, evidence-informed management of sporotrichosis across diverse healthcare settings and patient populations.</description>
    <category>Sporotrichosis</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Anthrax as a Biological Weapon, 2002</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1001-jama-287-17-2236-2c837dac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1001-jama-287-17-2236-2c837dac/</guid>
    <pubDate>Wed, 01 May 2002 00:00:00 GMT</pubDate>
    <description>By consolidating diagnostic, therapeutic, prophylactic, vaccination, surveillance, and decontamination guidance into a single consensus document informed by the 2001 attacks, the paper is positioned as a reference for preparedness and response to bioterrorism involving anthrax.</description>
    <category>Anthrax</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
</channel>
</rss>
